HealthTab and Abbott Expand UK Point-of-Care Testing
Vancouver, British Columbia, August 20, 2026 Avricore Health Inc. has announced that its wholly owned subsidiary, HealthTab Ltd., has...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Vancouver, British Columbia, August 20, 2026 Avricore Health Inc. has announced that its wholly owned subsidiary, HealthTab Ltd., has...
Silver Spring, Maryland, August 18, 2026 The U.S. Food and Drug Administration (FDA) has issued a new discussion paper...
SHANGHAI and HONG KONG, August 18, 2026 Antengene Corporation Limited, a commercial-stage global biotechnology company focused on innovative therapies...
CAMPBELL, Calif., August 18, 2026 Enlil, Inc. has introduced a four-layer governed AI architecture designed to help medical device...
TORONTO, July 16, 2026 SpinaFX Medical Inc. has achieved a significant regulatory milestone with the Medical Device Regulation (MDR)...
SOPHIA ANTIPOLIS, France, July 2, 2026 Median Technologies has announced that its eyonis® LCS, an artificial intelligence (AI)-powered Software...
WHITE PLAINS, NEW YORK, UNITED STATES — February 16, 2026 Retia Medical has received U.S. FDA 510(k) clearance for...
KEELE, United Kingdom, Feb. 5, 2026 — Biocomposites announced that its STIMULAN® Rapid Cure and STIMULAN® Kit have received...
SUNNYVALE, Calif. | January 5, 2026 — Ceribell has received FDA Breakthrough Device Designation for its Large Vessel Occlusion...
ROSWELL, Ga., December 29, 2025 — StimLabs has announced that the U.S. Food and Drug Administration (FDA) has granted...
